3
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Processes of Care During a Randomized Trial of Office-based Treatment of Opioid Dependence in Primary Care

Pages S67-S78 | Published online: 10 Jul 2009

References

  • Fiellin DA, O'Connor PG.. New federal initiatives to enhance the medical treatment of opioid dependence. Ann Intern Med. 2002; 137: 688–692
  • Fiellin DA, O'Connor PG.. Office-based treatment of opioid-dependent patients. New Eng J Med. 2002; 347: 817–823. [CROSSREF]
  • Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski MC, Schottenfeld RC.. Treatment of opiate dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse. 2002; 28: 231–241. [CROSSREF]
  • Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS.. Methadone maintenance in primary care: a randomized controlled trial. JAMA. 2001; 286: 1724–1731. [CROSSREF]
  • O'Connor PG, Waugh ME, Carroll KM, Rounsaville BJ, Diagkogiannis IA, Schottenfeld RS.. Primary care-based ambulatory opioid detoxification: the results of a clinical trial. J Gen Intern Med. 1995; 10: 255–260
  • O'Connor PG, Waugh ME, Schottenfeld RS, Diakogiannis IA, Rounsaville BJ.. Ambulatory opiate detoxification and primary care: a role for the primary care physician. J Gen Intern Med. 1992; 7: 532–534
  • O'Connor PG, Oliveto AH, Shi JM, et al, A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. Am J Drug Alcohol Abuse. 1996; 22: 523–531
  • Salsitz EA, Joseph H, Frank B, et al, Methadone Medical Maintenance (MMM): treating chronic opioid dependence in private medical practice —A summary report (1983-1998). Mt Sinai J Med. 2000; 67: 388–397
  • Novick DM, Joseph H, Salsitz EA, et al, Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): follow-up at three and a half to nine and a fourth years. J Gen Intern Med. 1994; 9: 127–130
  • Novick DM, Pascarelli EF, Joseph H, et al, Methadone maintenance patients in general medical practice: a preliminary report. JAMA. 1988; 259: 3299–3302. [CROSSREF]
  • Senay EC, Barthwell AG, Marks R, Boros P, Gillman D, White G.. Medical maintenance: a pilot study. J Addict Dis. 1993; 12: 59–76
  • Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M.. A 12-year follow-up of a methadone medical maintenance program. Am J Addict. 1999; 8: 293–299. [CROSSREF]
  • D'Aunno TD, Vaughn TE.. Variations in methadone treatment practices. JAMA. 1992; 267: 253–258. [CROSSREF]
  • Strain EC, Stitzer ML, Liebson IA, Bigelow GE.. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med. 1993; 119: 23–37
  • Strain EC, Bigelow GE, Liebson IA, Stitzer ML.. Moderate- vs high-dose methadone in the treatment of opioid: dependence a randomized trial. JAMA. 1999; 281: 1000–1005. [CROSSREF]
  • McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993; 269: 1953–1959. [CROSSREF]
  • Kraft KM, Rothbard AB, Hadley TR, McLellan AT, Asch DA.. Are supplementary services provided during methadone maintenance really cost-effective?. Am J Psychiatry. 1997; 154: 1214–1219
  • Fiellin DA, Storti SA, Schottenfeld RS, Biscoe JD, Pantalon MV, O'Connor PG. Methadone Medical Maintenance: A Training and Resource Guide for Office-based Physicians, Providence: Addiction Technology Transfer Center of New England; 2002. Available at:. http://center.butler.brown.edu/ATTC-NE/pubs/OBOT/OBOT.html
  • McLellan AT, Kushner H, Metzger D, et al, The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9: 199–213. [CROSSREF]
  • McLellan TA, Zanis D, Incmikoski R.. Treatment Service Review, Philadelphia: The Center for Studies in Addiction, Department of Psychiatry: Philadelphia VA Medical Center & The University of Pennsylvania;. 1989
  • Strang J, Sheridan J.. Effect of government recommendations on methadone prescribing in southeast England: comparison of 1995 and 1997 surveys. BMJ. 1998; 317: 1489–1490
  • Strang J, Sheridan J.. Methadone prescribing to opiate addicts by private doctors: comparison with NHS practice in southeast England. Addiction. 2001; 96: 567–576. [CROSSREF]
  • Strang J, Sheridan J.. Effect of national guidelines on prescription of methadone: analysis of NHS prescription data. England, 1990–2001, BMJ. 2003; 327: 321–322. [CROSSREF]
  • Weinrich M, Stuart M.. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. JAMA. 2000; 283: 1343–1348. [CROSSREF]
  • Wells KB, Sherbourne C, Schoenbaum M, et al, Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial, [erratum appears in JAMA 2000 Jun 28;283(24):3204]. JAMA. 2000; 283: 212–220. [CROSSREF]
  • Sherbourne CD, Wells KB, Duan N, et al, Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry. 2001; 58: 696–703. [CROSSREF]
  • Rounsaville BJ, Kosten TR.. Treatment for opioid dependence: quality and access. JAMA. 2000; 283: 1337–1339. [CROSSREF]
  • Brooner RK, King VL, Kidorf M, Schmidt CWJ.. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997; 54: 71–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.